The therapeutic monoclonal antibody market

Since the commercialization of the first therapeutic monoclonal antibody product in 1986, this class of biopharmaceutical products has grown significantly so that, as of November 10, 2014, forty-seven monoclonal antibody products have been approved in the US or Europe for the treatment of a variety...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	mAbs 2015-01, Vol.7 (1), p.9-14
Hauptverfasser:	Ecker, Dawn M, Jones, Susan Dana, Levine, Howard L
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - economics Antibodies, Monoclonal - therapeutic use Drug Approval Europe Humans Marketing Reviews United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!